ASX - By Stock
|
CGR |
Re:
Ann: Webb Project Drilling Update
|
|
Alf107
|
157 |
36K |
0 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
157
|
36K
|
0
|
|
ASX - By Stock
|
CGR |
Re:
Ann: Webb Project Drilling Update
|
|
Alf107
|
157 |
36K |
1 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
157
|
36K
|
1
|
|
ASX - By Stock
|
CGR |
Re:
Ann: Webb Project Drilling Update
|
|
Alf107
|
157 |
36K |
1 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
157
|
36K
|
1
|
|
ASX - By Stock
|
CGR |
Re:
Ann: Webb Project Drilling Update
|
|
Alf107
|
157 |
36K |
5 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
157
|
36K
|
5
|
|
ASX - By Stock
|
CGR |
Re:
Ann: Webb Project Drilling Update
|
|
Alf107
|
157 |
36K |
1 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
157
|
36K
|
1
|
|
ASX - By Stock
|
CGR |
Re:
Ann: Webb Project Drilling Update
|
|
Alf107
|
157 |
36K |
0 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
157
|
36K
|
0
|
|
ASX - By Stock
|
CGR |
Re:
Ann: Webb Project Drilling Update
|
|
Alf107
|
157 |
36K |
2 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
157
|
36K
|
2
|
|
ASX - By Stock
|
CGR |
Re:
Ann: Webb Project Drilling Update
|
|
Alf107
|
157 |
36K |
3 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
157
|
36K
|
3
|
|
ASX - By Stock
|
CGR |
Re:
Ann: Webb Project Drilling Update
|
|
Alf107
|
157 |
36K |
6 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
157
|
36K
|
6
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.1K |
396K |
0 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
1.1K
|
396K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
Alf107
|
234 |
57K |
4 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
234
|
57K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
Alf107
|
234 |
57K |
12 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
234
|
57K
|
12
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
Alf107
|
234 |
57K |
13 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
234
|
57K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Race options thread
|
|
Alf107
|
928 |
242K |
10 |
06/05/24 |
06/05/24 |
ASX - By Stock
|
928
|
242K
|
10
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.1K |
396K |
2 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
1.1K
|
396K
|
2
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.1K |
396K |
0 |
04/05/24 |
04/05/24 |
ASX - By Stock
|
1.1K
|
396K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Corporate Spotlight Advertisement.on HC
|
|
Alf107
|
37 |
11K |
13 |
03/05/24 |
03/05/24 |
ASX - By Stock
|
37
|
11K
|
13
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
21K |
7.1M |
12 |
28/04/24 |
28/04/24 |
ASX - By Stock
|
21K
|
7.1M
|
12
|
|
ASX - By Stock
|
CGR |
Re:
Ann: Completion of Ground Geophysics Enhances Targets
|
|
Alf107
|
358 |
90K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
358
|
90K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RC220 cGMP Manufacturing Complete
|
|
Alf107
|
76 |
25K |
23 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
76
|
25K
|
23
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
21K |
7.1M |
26 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
21K
|
7.1M
|
26
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.1K |
396K |
3 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
1.1K
|
396K
|
3
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.1K |
396K |
2 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
1.1K
|
396K
|
2
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.1K |
396K |
4 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
1.1K
|
396K
|
4
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.1K |
396K |
2 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
1.1K
|
396K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
Alf107
|
113 |
25K |
2 |
16/12/23 |
16/12/23 |
ASX - By Stock
|
113
|
25K
|
2
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
21K |
7.1M |
20 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
21K
|
7.1M
|
20
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Alf107
|
10K |
3.7M |
14 |
29/11/23 |
29/11/23 |
General
|
10K
|
3.7M
|
14
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Alf107
|
10K |
3.7M |
42 |
29/11/23 |
29/11/23 |
General
|
10K
|
3.7M
|
42
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
Alf107
|
508 |
123K |
6 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
508
|
123K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Prospectus
|
|
Alf107
|
226 |
54K |
7 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
226
|
54K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Prospectus
|
|
Alf107
|
226 |
54K |
19 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
226
|
54K
|
19
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Alf107
|
10K |
3.7M |
13 |
22/11/23 |
22/11/23 |
General
|
10K
|
3.7M
|
13
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.1K |
396K |
2 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
1.1K
|
396K
|
2
|
|
ASX - By Stock
|
|
Re:
Qbiotics
|
|
Alf107
|
1.1K |
396K |
2 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
1.1K
|
396K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
Alf107
|
231 |
65K |
15 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
231
|
65K
|
15
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
Alf107
|
231 |
65K |
7 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
231
|
65K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Impressive Bisantrene Phase 2 AML Clinical Results
|
|
Alf107
|
231 |
65K |
27 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
231
|
65K
|
27
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Alf107
|
10K |
3.7M |
23 |
07/11/23 |
07/11/23 |
General
|
10K
|
3.7M
|
23
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
Alf107
|
2.1K |
695K |
21 |
09/10/23 |
09/10/23 |
ASX - By Stock
|
2.1K
|
695K
|
21
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
21K |
7.1M |
4 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
21K
|
7.1M
|
4
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
21K |
7.1M |
5 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
21K
|
7.1M
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
21K |
7.1M |
16 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
21K
|
7.1M
|
16
|
|
ASX - By Stock
|
RAC Biotech |
Re:
Large BUY - ex insider/ ex CSO / new consultant - Dr Tillett
|
|
Alf107
|
143 |
51K |
20 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
143
|
51K
|
20
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
21K |
7.1M |
5 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
21K
|
7.1M
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
21K |
7.1M |
7 |
17/08/23 |
17/08/23 |
ASX - By Stock
|
21K
|
7.1M
|
7
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Alf107
|
21K |
7.1M |
17 |
11/08/23 |
11/08/23 |
ASX - By Stock
|
21K
|
7.1M
|
17
|
|
ASX - By Stock
|
RAC |
Re:
$2 and $1 targets... Yucky wouldn't touch it with yours
|
|
Alf107
|
438 |
175K |
1 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
438
|
175K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
$2 and $1 targets... Yucky wouldn't touch it with yours
|
|
Alf107
|
438 |
175K |
3 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
438
|
175K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
$2 and $1 targets... Yucky wouldn't touch it with yours
|
|
Alf107
|
438 |
175K |
7 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
438
|
175K
|
7
|
|